Liverpool target PSG star Barcola after Wirtz with transfer spending to top £300MILLION – and haven't ruled out Isak
LIVERPOOL are set to swoop for Paris Saint-Germain star Bradley Barcola — pushing their summer spending over £300MILLION.
The Premier League champs intend to spend big on another attacker even after they complete a British-transfer record £127million deal for Bayer Leverkusen's Florian Wirtz.
5
5
And they are prepared to battle Bayern Munich for £100m-rated winger Barcola, 22.
Liverpool have also not given up all hope of prising Alexander Isak away from Newcastle.
Kop chiefs would still love 23-goal Isak to lead their new-look frontline.
But if the Toon insist on a fee of around £150m for the 25-year-old Sweden international, Liverpool will bow out and look for an alternative.
And Barcola has emerged as a spectacular Plan B after doubts emerged over his future with Champions League winners PSG.
The Anfield giants have already spent £29.5m on Wirtz's Leverkusen team-mate, defender Jeremie Frimpong, 24, with another £40m-plus earmarked for Bournemouth's 21-year-old left-back Milos Kerkez.
But it is the prospect of Barcola teaming up with Wirtz, 22, and Anfield icon Mo Salah, 32, which will have fans pinching themselves.
Barcola, who is Bayern's No 1 target, is no longer part of PSG's first-choice front three.
JOIN SUN VEGAS: GET £50 BONUS
5
He found himself on the bench again for last month's Champions League final against Inter Milan, coming on in the 67th minute and teeing up Senny Mayulu for the last goal in the 5-0 thrashing.
Bayern have made no secret of their intention to test PSG's resolve to keep Barcola, who they signed from Lyon for £38m in 2023.
Liverpool will look to raise funds by offloading erratic forward Darwin Nunez, 25, and will also consider offers for 28-year-old pair Luis Diaz and Diogo Jota.
5
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
32 minutes ago
- Reuters
US FDA puts on hold Rein Therapeutics' lung disease drug trial
June 12 (Reuters) - Rein Therapeutics (RNTX.O), opens new tab has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after the Food and Drug Administration placed a clinical hold, the drug developer said on Thursday. Shares of the company fell nearly 10% after the bell. The company was testing a drug named LTI-03 to treat patients with idiopathic pulmonary fibrosis (IPF). The disease causes scarring of the lungs that makes it harder for them to work properly. Rein said in a filing that it is actively working with the FDA to remove the clinical hold. The FDA and Rein did not immediately respond to Reuters' requests for comment on why the hold was placed. The drug was well-tolerated and safe in an early-stage study in patients with IPF, the company said in the filing. No drug-related serious adverse events have been reported in any studies treating patients with LTI-03, it added. Rein continues to study the drug and enroll patients in Australia and Europe.
Times
35 minutes ago
- Times
KPMG fined over partner error in Carr's audit
KPMG has been fined just shy of £700,000 for not realising that a senior partner at another firm had been working on the audit of a subsidiary of Carr's, the agriculture and engineering company, for a year too long. The Financial Reporting Council determined that KPMG, as Carr's main auditor, was wrong to rely on the work of another audit firm responsible for signing off the 2021 accounts of the subsidiary because the lead partner had held that role for six years, one more than is permitted. The FRC did not name the other firm, but Companies House filings show Mitchell Charlesworth, a small accountancy group based in the northwest of England, audited the 2021 accounts of Carr's Billington Agriculture (Operations), a manufacturer and supplier of animal feed. Mitchell Charlesworth also provided tax and accountancy services to Carrs Billington Agriculture, which was another reason why KPMG should not have signed off on the group accounts. The regulator, in a 35-page report, said that KPMG had failed to 'ensure compliance with applicable independence requirements'. Lead audit partners, also known as audit engagement partners, are required to rotate every five years to prevent them from becoming too chummy with the management. Audit firms are also limited on how much non-audit work they can do for clients for fear that it might influence their decision-making. Carr's traces its roots to 1831 and a flour mill opened by Jonathan Carr to supply his Table Water biscuit factory. In 1908, the flour-milling assets were spun off into what is now Carr's Group. Carr's 2022 accounts were delayed for several months because Grant Thornton, which took over from KPMG, felt that, owing to 'independence reasons', it could not rely on the work of the auditor of one of Carr's subsidiaries. Jamie Symington, deputy executive counsel at the FRC, said KPMG's breaches were 'serious', even though the quality of KPMG's audit work was 'not brought into question'. KPMG was initially fined £1.25 million, but this was cut to £690,625 because of its 'exceptional cooperation during the investigation'. It has also paid the FRC's investigation costs of £219,755. Nick Plumb, who was KPMG's lead partner on the Carr's audits, was fined £70,000, which was cut to £38,675. Plumb, 59, retired from the KPMG partnership in 2022. The fine money goes to the Department for Business and Trade. Symington said KPMG's failings were 'basic and fundamental', adding: 'It is of fundamental importance that when seeking to rely on the work of a component auditor, the group audit firm can be satisfied that its independence is not compromised as a result of conditions that would compromise the independence of another firm on whose work it relies.' 'We accept that we did not meet the required standards in this instance,' Cath Burnet, head of audit at KPMG UK, said.
Daily Mail
42 minutes ago
- Daily Mail
Warhammer maker Games Workshop to reward staff with £20MILLION payout
Games Workshop is handing its employees £20million following another bumper year for the beloved tabletop games maker. The Warhammer creator, which has struck a deal to have its creations star in potential TV and film blockbusters for Amazon, said the cash payments would be given on 'an equal basis' to every staff member. Games Workshop's shares have soared in recent years and it joined the UK's leading FTSE 100 stock market index for the first time last December. The £20million payout represents an increase on the £18million awarded last year and £11million the year before that. It comes as Games Workshop forecast sales to soar to at least £560million for the year ending 1 June, up from £494.7million in the previous 12 months. British actor and Superman star Henry Cavill, a self-declared lifelong fan of the figures, will star in and produce a Warhammer 40,000 series with Amazon Prime and Games Workshop. Last December, Cavill posted on Instagram: 'To celebrate some Warhammer news, I decided to make a pilgrimage to the very first place I bought Warhammer models over 30 years Little Shop, on my home island of Jersey! 'My incredible team and I, alongside the brilliant minds at Games Workshop, have been working away in concept rooms, breaking down approaches to the enormity and magnificence of the Warhammer world. 'Together, we've been sifting through the plethora of incredible characters and poring over old tomes and texts. 'Our combined efforts have led us to a fantastic place to start our Universe, which has been agreed upon by those up on high at both Amazon and Games Workshop. That starting place shall, for now, remain a secret.' Games Workshop said today that it expects to achieve record licensing sales of about £50million, although the company does not envision repeating that figure in the next financial year. Alongside this, the business believes its core operating profits and pre-tax profits will total no less than £210million and £255million, respectively. Two months ago, Games Workshop upgraded its earnings forecast thanks to strong trading across licensing and its core operations. This followed the firm's best-ever first-half result, with sales buoyed by record retail sales in the UK, North America and Continental Europe. Revenues were further boosted by the release of video game Warhammer 40,000: Space Marine 2, which sold two million copies on the opening day of its launch and five million by the end of November. During the half-year period, Games Workshop agreed 'creative guidelines' with Amazon to adapt Warhammer 40,000 into films and television shows. In addition, the company entered the blue-chip FTSE 100 after enjoying nearly a decade of consistent growth under its chief executive, Kevin Rountree. During his tenure, Games Workshop has improved its relationship with fans and introduced games with more simplified rules, including Blood Bowl, a parody of American football. Its revenues benefited considerably from the Covid-19 pandemic, when consumers sought new indoor hobbies to occupy their time. Although lockdown curbs eventually ended, the firm's trade has continued expanding, and its market value now stands at almost £5billion. Russ Mould, investment director at AJ Bell, said: 'Games Workshop has a rock-solid core business, underpinned by an army of fans emerged in its fantasy worlds who collect miniature figures and play its board games. 'This success has enabled the company to build a rich library of intellectual property that is now the platform for additional revenue generation. 'Licencing the rights to certain brands and characters is easy money, but Games Workshop is fiercely protective of its assets and won't let anyone come along and milk them.' Despite the optimistic forecasts, Games Workshop shares were 4.5 per cent lower at 15,150p on Friday morning, making them the Footsie's biggest faller.
